Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy STERIS stock
Learn how to easily invest in STERIS stock.
STERIS plc is a medical devices business based in the US. STERIS shares (STE) are listed on the NYSE and all prices are listed in US Dollars. STERIS employs 16,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in STERIS
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – STE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
STERIS stock price (NYSE: STE)Use our graph to track the performance of STE stocks over time.
STERIS shares at a glance
|Latest market close||$208.73|
|52-week range||$192.40 - $255.43|
|50-day moving average||$219.48|
|200-day moving average||$227.68|
|Wall St. target price||$263.80|
|Dividend yield||$1.69 (0.82%)|
|Earnings per share (TTM)||$2.48|
Buy STERIS shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy STERIS stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
STERIS price performance over time
|1 week (2022-06-29)||0.19%|
|1 month (2022-06-03)||-5.32%|
|3 months (2022-04-06)||-16.12%|
|6 months (2022-01-06)||-12.47%|
|1 year (2021-07-06)||-0.94%|
|2 years (2020-07-06)||35.85%|
|3 years (2019-07-05)||36.62%|
|5 years (2017-07-06)||158.23%|
Is STERIS stock undervalued or overvalued?
Valuing STERIS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STERIS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STERIS's P/E ratio
STERIS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 85x. In other words, STERIS shares trade at around 85x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
STERIS's PEG ratio
STERIS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4056. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into STERIS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
STERIS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.
The EBITDA is a measure of a STERIS's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.6 billion|
|Operating margin TTM||13.77%|
|Gross profit TTM||$2 billion|
|Return on assets TTM||4.39%|
|Return on equity TTM||4.65%|
|Market capitalisation||$21.1 billion|
TTM: trailing 12 months
STERIS share dividends
Dividend payout ratio: 21.74% of net profits
Recently STERIS has paid out, on average, around 21.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), STERIS shareholders could enjoy a 0.82% return on their shares, in the form of dividend payments. In STERIS's case, that would currently equate to about $1.69 per share.
While STERIS's payout ratio might seem low, this can signify that STERIS is investing more in its future growth.
STERIS's most recent dividend payout was on 27 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 June 2022 (the "ex-dividend date").
Have STERIS's shares ever split?
STERIS's shares were split on a 2:1 basis on 24 August 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your STERIS shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for STERIS shares which in turn could have impacted STERIS's share price.
STERIS share price volatility
Over the last 12 months, STERIS's shares have ranged in value from as little as $192.4 up to $255.4342. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while STERIS's is 0.6633. This would suggest that STERIS's shares are less volatile than average (for this exchange).
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.
STERIS in the news
Here's Why Investors Should Retain STERIS (STE) Stock for Now
STERIS plc's (NYSE:STE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Steris (STE) Up 1.5% Since Last Earnings Report: Can It Continue?
Frequently asked questionsWhat percentage of STERIS is owned by insiders or institutions?
Currently 0.303% of STERIS shares are held by insiders and 95.382% by institutions. How many people work for STERIS?
Latest data suggests 16,000 work at STERIS. When does the fiscal year end for STERIS?
STERIS's fiscal year ends in March. Where is STERIS based?
STERIS's address is: 70 Sir John Rogerson?s Quay, Dublin, Ireland, D02 R296 What is STERIS's ISIN number?
STERIS's international securities identification number is: IE00BFY8C754 What is STERIS's CUSIP number?
STERIS's Committee on Uniform Securities Identification Procedures number is: 859152100
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert